NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience for the treatment of narcolepsy; and N...
Industry: Biotechnology
Sector: Healthcare
Phone: 41 44 512 21 50
Fax: 41 44 512 21 51
Address:
The Circle 6, Zurich, Switzerland
